When OpenAI introduced ChatGPT Health to help consumers direct their health and wellness questions to its now ubiquitous bot, the chief medical officer of the dominant electronic health record company
Solera Health Launches Behavioral Health Network with Calm and Lyra
Solera Health, a digital health delivery company, unveiled its new behavioral health network on Tuesday with Calm Health and Lyra Health as partners. Phoenix, Arizona-based Solera Health works with payers
Eli Lilly Joins Chase for Hot Inflammation Target, Paying $100M for Rights to CSL Drug
Eli Lilly has been scouting for drugs to follow the trail blazed by its blockbuster cardiometabolic medicines. Its latest pipeline-building deal has the pharmaceutical company paying $100 million for rights
Ocular Therapeutix Eyes FDA Filing After Wet AMD Drug Tops Regeneron’s Eylea in Phase 3 Test
An Ocular Therapeutix drug developed for the wet form of age-related macular degeneration was better at helping patients maintain vision compared to a blockbuster Regeneron Pharmaceuticals drug that is a
Daffodil Health Secures $16.3M for Health Plan Administration Platform
Daffodil Health, an AI platform for health plan administration and claims processing, has raised $16.3 million in Series A funding to help scale the company, it announced on Tuesday. The
Regulatory Innovation as a Catalyst: How New Compliance Strategies Are Speeding Up Healthcare Technology Adoption
The speed at which medical technology is developing is remarkable. Hospitals are integrating cutting-edge tools into their clinical workflows at a rate that would have been hard to envision ten
From Pilots to Protocols: Why VR Therapy Needs Dosage Standards to Become Real Clinical Care
Virtual reality therapy has a strange problem. It can look clinically useful within minutes. A patient puts on a headset. Their attention shifts. Pain ratings drop. Anxiety eases. Clinicians see
NYU Langone Health: We’re Close to Clinical AI with No Human in the Loop
The medical community’s comfort with deploying AI in clinical care is rapidly evolving — because it has to, according to health informatics leaders at NYU Langone Health. They said that
Disc Medicine Rare Disease Drug Picked for Faster Regulatory Review Is Rejected by the FDA
Disc Medicine’s effort to introduce a new therapy for a rare blood disorder with few treatment options has been derailed with the FDA turning down the application and asking for
This Diagnostic Company Is Rapidly Expanding in Emerging Markets: What to Know
Patient care improves when people get accurate test results from an excellent diagnostic company. Health care professionals can find the best partners in sample processing by learning which diagnostic companies









